Can You Claim Wegovy on Private Health Insurance?

What the evidence says about Wegovy's standing with UK insurers

NICE recommended semaglutide for weight management in March 2023, under Technology Appraisal TA875. That recommendation came with strict conditions: use within a specialist weight management service, for a maximum of two years, for adults with a BMI of 35 or above and at least one weight-related condition (with lower thresholds for some ethnic backgrounds). This clinical endorsement has prompted some private insurers to review their exclusions, but it has not produced a consistent industry-wide change.

In clinical trials, semaglutide 2.4mg produced an average weight reduction of around 15% over 68 weeks, as reported in the STEP 1 trial published in the New England Journal of Medicine. Insurers assessing value are weighing that evidence against the monthly cost of prescribing. The result, for now, is a patchwork: some corporate health schemes (particularly those run by larger employers) have added a weight-management medicine benefit. Most individual policies have not.

The practical first step is to read your policy's exclusion list carefully. Look under "weight management", "obesity", "lifestyle conditions", and "prescription medicines". If the wording is ambiguous, call your insurer directly and ask specifically about semaglutide and brand-name Wegovy. Get any answer in writing. Some plans cover the consultation and prescriber fees but not the medicine itself; others cover neither. A very small number cover both, subject to a referral from a private specialist.

Why private health insurance cover for weight-loss medicines lags behind

Weight management has long been treated by UK insurers as a "lifestyle" category rather than a clinical one, which is why exclusions were written into most policy small print well before GLP-1 medicines existed. The classification is changing, slowly. Obesity is recognised by NHS England and by NICE as a chronic condition with serious health consequences, and the evidence base for medicines like semaglutide has strengthened considerably in recent years. If you want to understand the broader treatment options available privately, the weight-loss treatments overview sets out what is currently licensed in the UK.

For many policyholders, the relevant question is whether their insurer will cover the associated costs (the private consultation, the specialist review, the prescription fee) even when the medicine itself is excluded. Some will. It is worth asking separately about each component rather than treating the question as all-or-nothing.

Corporate schemes are the most promising avenue. If your employer offers private health cover, ask HR or your benefits provider whether weight-management medicines are included, or whether a policy upgrade is available. A number of large UK employers added this benefit in 2024 and 2025 as the evidence mounted. If you are self-employed or hold an individual policy, the outlook is less certain.

If your insurer doesn't cover it: the private self-pay route

For most people in the UK who want Wegovy and either don't qualify for NHS access or don't want to wait, self-pay through a regulated private pharmacy or clinic is the practical route. The cost of Wegovy as a private prescription varies by dose and provider, and a legitimate price always includes the prescriber assessment and prescription fee, be cautious of any quote that doesn't.

What that process actually looks like at a private Wegovy prescription service: you complete a medical consultation, a GPhC-registered Independent Prescriber reviews your answers and health information (not software, a real clinician) and, if you are suitable, a prescription is issued and the treatment is dispensed. At nume, if you order before noon on a working day and your consultation is approved, your treatment goes out the same day and arrives the next working day via DPD, in plain packaging. Your pen then lives in the fridge until your weekly injection day, many people tuck it in the fridge door and set a phone reminder for the same time each week.

If you have been seen by a private specialist and have documentation of that assessment, some services will accept a transfer to self-pay without starting from scratch. Worth asking when you contact a pharmacy.

What to check before your next steps

A few practical things worth confirming before you decide on a route. First, whether your insurer has updated its formulary since your policy was issued, the position a year ago may not reflect what is covered today. Second, whether your policy distinguishes between a private Wegovy clinic appointment (which it may cover) and an online pharmacy consultation (which it may not). Third, whether a GP referral letter would help your insurance claim, even if the NHS itself cannot prescribe Wegovy on your behalf currently.

If you want to understand the full picture of going private for Wegovy in the UK, including what a private clinic appointment involves versus an online pharmacy, that is worth reading before committing to any one route. The full Wegovy overview covers the medicine's licensing, how it works, and what to expect. And if you have a specific question about suitability, our FAQs address the most common ones.

For most people, the consultation is the natural starting point regardless of how treatment is funded. A prescriber can only confirm suitability once they have reviewed your health information, and that step is required whether an insurer is paying or you are, including when you choose to get the Wegovy jab privately through a self-pay route. When you are ready, check your eligibility with our prescribers, at no charge.